Structural Basis of Resistance to Anti-Cytochrome bc1 Complex Inhibitors: Implication for Drug Improvement
- 1 February 2014
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 20 (5), 704-724
- https://doi.org/10.2174/138161282005140214163327
Abstract
The emergence of drug resistance has devastating economic and social consequences, a testimonial of which is the rise and fall of inhibitors against the respiratory component cytochrome bc1 complex, a time tested and highly effective target for disease control. Unfortunately, the mechanism of resistance is a multivariate problem, including primarily mutations in the gene of the cytochrome b subunit but also activation of alternative pathways of ubiquinol oxidation and pharmacokinetic effects. There is a considerable interest in designing new bc1 inhibitors with novel modes of binding and lower propensity to induce the development of resistance. The accumulation of crystallographic data of bc1 complexes with and without inhibitors bound provides the structural basis for rational drug design. In particular, the cytochrome b subunit offers two distinct active sites that can be targeted for inhibition - the quinol oxidation site and the quinone reduction site. This review brings together available structural information of inhibited bc1 by various quinol oxidation- and reductionsite inhibitors, the inhibitor binding modes, conformational changes upon inhibitor binding of side chains in the active site and large scale domain movements of the iron-sulfur protein subunit. Structural data analysis provides a clear understanding of where and why existing inhibitors fail and points towards promising alternatives.Keywords
This publication has 93 references indexed in Scilit:
- Cytochrome b Mutation Y268S Conferring Atovaquone Resistance Phenotype in Malaria Parasite Results in Reduced Parasite bc1 Catalytic Turnover and Protein Expression*Published by Elsevier BV ,2012
- Arrangement of electron transport chain components in bovine mitochondrial supercomplex I1III2IV1The EMBO Journal, 2011
- Loss of a Conserved Tyrosine Residue of Cytochrome b Induces Reactive Oxygen Species Production by Cytochrome bc1Published by Elsevier BV ,2011
- NMR Investigations of the Rieske Protein from Thermus thermophilus Support a Coupled Proton and Electron Transfer MechanismJournal of the American Chemical Society, 2010
- Ascochlorin is a novel, specific inhibitor of the mitochondrial cytochrome bc1 complexBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- Probing binding determinants in center P of the cytochrome bc1 complex using novel hydroxy-naphthoquinonesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- Subnanomolar Inhibitor of Cytochrome bc1 Complex Designed by Optimizing Interaction with Conformationally Flexible ResiduesJournal of the American Chemical Society, 2009
- The role of molecular modeling in the design of analogues of the fungicidal natural products crocacins A and DBioorganic & Medicinal Chemistry, 2008
- Structure of the Cytochrome b6f Complex: Quinone Analogue Inhibitors as Ligands of Heme cnJournal of Molecular Biology, 2007
- Surface-modulated motion switch: Capture and release of iron–sulfur protein in the cytochrome bc 1 complexProceedings of the National Academy of Sciences of the United States of America, 2006